BridgeBio Oncology Therapeutics, Inc. BBOT
2.17 USD -0.13 (-5.65%)
At closeNov 5, 2026, 4:00 PM EST
2.17 0.00 0.00%
After hours · Nov 5, 4:00 PM ET
2.08 Day range 2.30
2.08 52-week range 14.87
- YTD
- -82.67%
- 1 year
- -82.50%
News
benzinga.com Morgan Stanley Maintains Overweight on BridgeBio Oncology, Lowers Price Target to $13 Morgan Stanley analyst Sean Laaman maintains BridgeBio Oncology (NASDAQ:BBOT) with a Overweight and lowers the price target from $18 to $13.
benzinga.com Oppenheimer Maintains Outperform on BridgeBio Oncology, Lowers Price Target to $16 Oppenheimer analyst Mazahir Alimohamed maintains BridgeBio Oncology (NASDAQ:BBOT) with a Outperform and lowers the price target from $22 to $16.
